Patent Yard Sign in
Expired Canadian patentCanada

Therapeutic nucleosides

CA 1285935 C · Owner: Wellcome Foundation Limited (The) · Inventors: Freeman, George Andrew; Barry, David Walter; Furman, Phillip Allen

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

3'-Azido-3'-deoxythymidine and its threo-3'-azido isomer and their pharmaceutically acceptable derivatives have been found to possess potent therapeutic activity, particularly against human and animal retroviral infections such as HTLV-I, HTLV-III and feline leukaemia virus as well as, against human and animal gram-negative bacterial infections.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted July 9, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 9, 2008.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 14, 1986
GrantedJuly 9, 1991
Term endedJuly 9, 2008
Patent numberCA 1285935 C
Classification (IPC)C07H19/06 +2 more

Timeline

Timeline From CIPO dates

19871990199319961999200220052008Application filedMarch 14, 1986Patent grantedJuly 9, 1991Term endedJuly 9, 2008

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.